The Platelet Derived Growth Factor Receptor Beta pipeline drugs market research report outlays comprehensive information on the Platelet Derived Growth Factor Receptor Beta targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Platelet Derived Growth Factor Receptor Beta pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Oncology, Respiratory, Infectious Disease, and Ophthalmology which include the indications Hepatocellular Carcinoma, Solid Tumor, Idiopathic Pulmonary Fibrosis, Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease), Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Pneumonia, Wet (Neovascular / Exudative) Macular Degeneration, and Glaucoma. It also reviews key players involved in Platelet Derived Growth Factor Receptor Beta targeted therapeutics development with respective active and dormant or discontinued products.
The Platelet Derived Growth Factor Receptor Beta pipeline targets constitutes close to 35 molecules. Out of which, approximately 32 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Pre-Registration, Filing rejected/ Withdrawn, Phase III, Phase II, Phase I, and Preclinical stages are 2, 1, 4, 11, 9, and 5 respectively. Similarly, the universities portfolio in Preclinical, and Discovery comprises 2, and 1 molecule.
Platelet Derived Growth Factor Receptor Beta overview
Platelet-derived growth factor receptor beta (PDGFR-β) is a tyrosine-protein kinase that acts as cell-surface receptor for homodimeric PDGFB and PDGFD and for heterodimers formed by PDGFA and PDGFB, and plays an essential role in the regulation of embryonic development, cell proliferation, survival, differentiation, chemotaxis, and migration.
For a complete picture of Platelet Derived Growth Factor Receptor Beta’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.